The company AsurBrok and the Biomedical Research Institute of Lleida (IRBLleida) sign a new collaboration agreement to promote research in Lleida.
AsurBrok is an insurance broker with more than 31 years of history and who works every day to give the best of themselves and get their customers to renew their confidence year after year.
The company signs this collaboration agreement for the fourth consecutive year. These collaborations allow research on very relevant diseases such as cancer, stroke, multiple sclerosis, diabetes, the nervous system, the cardiovascular system, among others, and help provide better services to the population.
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Palobiofarma S.L. is pleased to announce the “last patient last visi...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory